Publicacións en colaboración con investigadores/as de Hospital Universitario La Paz (10)

2023

  1. Endovascular thrombectomy first-pass reperfusion and ancillary device placement

    Journal of NeuroInterventional Surgery

2022

  1. Economic impact of the first pass effect in mechanical thrombectomy for acute ischaemic stroke treatment in Spain: A cost-effectiveness analysis from the national health system perspective

    BMJ Open, Vol. 12, Núm. 9

2021

  1. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies

    Frontiers in Neurology, Vol. 12

2020

  1. Executive Summary of the Consensus Statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Tropical Medicine and International Health (SEMTSI), the Spanish Association of Surgeons (AEC), the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), the Spanish Society of Thoracic Surgery (SECT), the Spanish Society of Vascular and Interventional Radiology (SERVEI), and the Spanish Society of Paediatric Infectious Diseases (SEIP), on the Management of Cystic Echinococcosis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 6, pp. 283-288

  2. Neonatal Infection Due to SARS-CoV-2: An Epidemiological Study in Spain

    Frontiers in Pediatrics, Vol. 8

  3. Temperature-induced changes in reperfused stroke: Inflammatory and thrombolytic biomarkers

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-12

  4. The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation

    Annals of Clinical and Translational Neurology, Vol. 7, Núm. 11, pp. 2103-2114

2018

  1. Detection of spleen, kidney and liver infarcts by abdominal computed tomography does not affect the outcome in patients with left-side infective endocarditis

    Medicine (United States), Vol. 97, Núm. 33

2011

  1. Low doses of bone morphogenetic protein 4 increase the survival of human adipose-derived stem cells maintaining their stemness and multipotency

    Stem Cells and Development, Vol. 20, Núm. 6, pp. 1011-1019